Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2013

View Archived Issues

KaloBios Pharmaceuticals prepares novel monoclonal antibodies for COPD

FDA grants second fast track designation for MABp1

Data from genome-wide association study in patients with anemia published

Computational integration of schizophrenia-related genomics uncovers functional gene networks

Novel candidate antidiabetic drugs patented by Ajinomoto

Roche presents new TaR-1 ligands

Novel HIV vaccine adjuvants created by French investigators

Arena Pharmaceuticals prepares new GPR119 receptor ligands

Researchers study novel PRMT5 inhibitors for the treatment of beta-thalassemia and SCD

FDA grants QIDP designation to Paratek Pharmaceuticals' omadacycline

FDA clears IND for TGR-1202 studies

Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna

Immunovaccine reports preclinical data on DepoVax-based anthrax vaccines

Investigators develop mouse model for evaluation of anti-human CD37 therapeutics

Philogen enters into worldwide licensing agreement with Pfizer for Dekavil

Savant obtains NIDA funding for preclinical development of 18-MC

Development of a low-cost, large-scale, multiplex-targeted, candidate gene mutation screen

FDA clears IND to investigate OrbeShield in GI-ARS

Receptos commences patient dosing in phase II trial of RPC-1063 in ulcerative colitis

Phase II trial of RM-493 for treatment of obesity begins

Data suggest 12-mg Proellex-V dose optimal for uterine fibroid treatment

Proteon Therapeutics reports results from study of recombinant human elastase

Bayer files application in Japan for use of VEGF TrapEye in macular edema following CRVO

iCo Therapeutics provides update on phase II iCo-007 trial

Biogen Idec files BLA for long-lasting factor IX therapy for hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...